Skip to main content

Table 2 Observed multi-drug resistance among tuberculosis cases in Jiangsu Province, China

From: Epidemiology of anti-tuberculosis drug resistance in a chinese population: current situation and challenges ahead

Category

Cases

Drug resistant†

MDR‡

  

HR

HRE

HRS

HRSE

 
  

n(%)

n(%)

n(%)

n(%)

n(%)

Total

1824

37(2.03)

26(1.43)

94(5.15)

146(8.00)

303(16.61)

New cases

1180

9(0.76)

5(0.42)

33(2.80)

43(3.64)

90(7.63)

Previously treated cases

644

28(4.35)

21(3.26)

61(9.47)

103(15.99)

213(33.07)

χ 2

 

26.95

23.87

37.98

86.29

194.76

P

 

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

  1. †: HR: isoniazid+rifampicin; HRE: isoniazid+rifampicin+ethambutol;
  2. HRS: isoniazid+rifampicin+streptomycin;
  3. HRSE: isoniazid+rifampicin+streptomycin+ethambutol
  4. ‡: MDR, resistant to at least isoniazid and rifampicin